Mersana Therapeutics buy Truist Financial Co.
Start price
29.02.24
/
50%
€5.00
Target price
28.02.25
€8.30
Performance (%)
-45.32%
Price
26.04.24
€2.73
Summary
This prediction is currently active. Massive losses of -45.32% have been the result for the BUY prediction by Truist_Financial_Co_. This prediction currently runs until 28.02.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Mersana Therapeutics | -10.507% | -10.507% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Mersana Therapeutics diskutieren
Mersana Therapeutics, Inc. (NASDAQ: MRSN) was upgraded by analysts at Truist Financial Co. from a "hold" rating to a "buy" rating. They now have a $9.00 price target on the stock.
Ratings data for MRSN provided by MarketBeat